Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction

Journal of the Formosan Medical Association

Volumn 116, Issue 1, 2017, Pages 41-48

  Liu, Chia Ming ^a,b   Peng, Chih Yu ^a,b   Liao, Yi Wen ^a   Lu, Ming Yi ^a,b   Tsai, Meng Lun ^a   Yeh, Jung Chun ^a,b   Yu, Chuan Hang ^a,b   Yu, Cheng Chia ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

cancer stemness; oral squamous cell carcinomas; sulforaphane

Indexed keywords

ALDH1 PROTEIN; HERMES ANTIGEN; MICRORNA 200C; PROTEIN; SULFORAPHANE; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTINEOPLASTIC AGENT; CD44 PROTEIN, MOUSE; ISOENZYME; ISOTHIOCYANIC ACID DERIVATIVE; MICRORNA; MIRN200 MICRORNA, MOUSE; RETINAL DEHYDROGENASE; SULFORAFAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER STEM CELL; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; MTT ASSAY; NONHUMAN; STEM CELL SELF-RENEWAL; TUMOR XENOGRAFT; ANIMAL; CARCINOMA, SQUAMOUS CELL; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; HUMAN; METABOLISM; MOUTH NEOPLASMS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HUMANS; ISOENZYMES; ISOTHIOCYANATES; MICE; MICE, NUDE; MICRORNAS; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE;

EID: 84957718256     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2016.01.004     Document Type: Article

References (41)

1. 1 Kamangar, F., Dores, G.M., Anderson, W.F., Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24 (2006), 2137–2150.
2. 2 Li, W.C., Lee, P.L., Chou, I.C., Chang, W.J., Lin, S.C., Chang, K.W., Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development. J Oral Pathol Med 44 (2015), 167–177.
3. 3 Visvader, J.E., Lindeman, G.J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008), 755–768.
4. 4 Dean, M., Fojo, T., Bates, S., Tumour stem cells and drug resistance. Nat Rev Cancer 5 (2005), 275–284.
5. 5 Chiou, S.H., Yu, C.C., Huang, C.Y., Lin, S.C., Liu, C.J., Tsai, T.H., et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14 (2008), 4085–4095.
6. 6 Chen, Y.S., Wu, M.J., Huang, C.Y., Lin, S.C., Chuang, T.H., Yu, C.C., et al. CD133/Src axis mediates tumor initiating property and epithelial–mesenchymal transition of head and neck cancer. PLoS ONE, 6, 2011, e28053.
7. 7 Clay, M.R., Tabor, M., Owen, J.H., Carey, T.E., Bradford, C.R., Wolf, G.T., et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32 (2010), 1195–1201.
8. 8 Wu, M.J., Jan, C.I., Tsay, Y.G., Yu, Y.H., Huang, C.Y., Lin, S.C., et al. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer, 9, 2010, 283.
9. 9 Yu, C.C., Hu, F.W., Yu, C.H., Chou, M.Y., Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinomas-derived side population cancer stem cells. Head Neck, 2014, 10.1002/hed.23975.
10. 10 Choi, S., Lew, K.L., Xiao, H., Herman-Antosiewicz, A., Xiao, D., Brown, C.K., et al. d,l-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis 28 (2007), 151–162.
11. 11 Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M.A., Chevolleau, S., et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60 (2000), 1426–1433.
12. 12 Bertl, E., Bartsch, H., Gerhauser, C., Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 5 (2006), 575–585.
13. 13 Rose, P., Huang, Q., Ong, C.N., Whiteman, M., Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 209 (2005), 105–113.
14. 14 Kensler, T.W., Egner, P.A., Agyeman, A.S., Visvanathan, K., Groopman, J.D., Chen, J.G., et al. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329 (2013), 163–177.
15. 15 Wang, H., Bian, S., Yang, C.S., Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 32 (2011), 1881–1889.
16. 16 Xu, C., Shen, G., Chen, C., Gelinas, C., Kong, A.N., Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24 (2005), 4486–4495.
17. 17 Li, Y., Zhang, T., Korkaya, H., Liu, S., Lee, H.F., Newman, B., et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 16 (2010), 2580–2590.
18. 18 Labsch, S., Liu, L., Bauer, N., Zhang, Y., Aleksandrowicz, E., Gladkich, J., et al. Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells. Int J Oncol 44 (2014), 1470–1480.
19. 19 Kallifatidis, G., Labsch, S., Rausch, V., Mattern, J., Gladkich, J., Moldenhauer, G., et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 19 (2011), 188–195.
20. 20 Yu, C.C., Chen, Y.W., Chiou, G.Y., Tsai, L.L., Huang, P.I., Chang, C.Y., et al. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 47 (2011), 202–210.
21. 21 Chang, Y.C., Jan, C.I., Peng, C.Y., Lai, Y.C., Hu, F.W., Yu, C.C., Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas. Oncotarget 6 (2015), 24002–24016.
22. 22 Yu, C.C., Tsai, L.L., Wang, M.L., Yu, C.H., Lo, W.L., Chang, Y.C., et al. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 73 (2013), 3425–3440.
23. 23 Lo, J.F., Yu, C.C., Chiou, S.H., Huang, C.Y., Jan, C.I., Lin, S.C., et al. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res 71 (2011), 1912–1923.
24. 24 Hu, F.W., Tsai, L.L., Yu, C.H., Chen, P.N., Chou, M.Y., Yu, C.C., Impairment of tumor-initiating stem-like property and reversal of epithelial–mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Mol Nutr Food Res 56 (2012), 1247–1258.
25. 25 Chou, M.Y., Hu, F.W., Yu, C.H., Yu, C.C., Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells. Oral Oncol 51 (2015), 31–39.
26. 26 Visus, C., Ito, D., Amoscato, A., Maciejewska-Franczak, M., Abdelsalem, A., Dhir, R., et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res 67 (2007), 10538–10545.
27. 27 Chen, Y.C., Chen, Y.W., Hsu, H.S., Tseng, L.M., Huang, P.I., Lu, K.H., et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 385 (2009), 307–313.
28. 28 Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., Kirchner, T., Opinion: migrating cancer stem cells — an integrated concept of malignant tumour progression. Nat Rev Cancer 5 (2005), 744–749.
29. 29 Liu, C., Tang, D.G., MicroRNA regulation of cancer stem cells. Cancer Res 71 (2011), 5950–5954.
30. 30 Lo, W.L., Yu, C.C., Chiou, G.Y., Chen, Y.W., Huang, P.I., Chien, C.S., et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 223 (2011), 482–495.
31. 31 Kato, M., Slack, F.J., microRNAs: small molecules with big roles — C. elegans to human cancer. Biol Cell 100 (2008), 71–81.
32. 32 Yu, S.L., Chen, H.Y., Chang, G.C., Chen, C.Y., Chen, H.W., Singh, S., et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13 (2008), 48–57.
33. 33 Seike, M., Goto, A., Okano, T., Bowman, E.D., Schetter, A.J., Horikawa, I., et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 106 (2009), 12085–12090.
34. 34 Iorio, M.V., Casalini, P., Tagliabue, E., Menard, S., Croce, C.M., MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 44 (2008), 2753–2759.
35. 35 Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99 (2002), 15524–15529.
36. 36 Calin, G.A., Croce, C.M., MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25 (2006), 6202–6210.
37. 37 Ventura, A., Jacks, T., MicroRNAs and cancer: short RNAs go a long way. Cell 136 (2009), 586–591.
38. 38 Li, J., Huang, H., Sun, L., Yang, M., Pan, C., Chen, W., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15 (2009), 3998–4008.
39. 39 Liu, C.J., Tsai, M.M., Hung, P.S., Kao, S.Y., Liu, T.Y., Wu, K.J., et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70 (2010), 1635–1644.
40. 40 Yang, M.H., Lin, B.R., Chang, C.H., Chen, S.T., Lin, S.K., Kuo, M.Y., et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 31 (2012), 2401–2411.
41. 41 Lu, Y.C., Chen, Y.J., Wang, H.M., Tsai, C.Y., Chen, W.H., Huang, Y.C., et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila) 5 (2012), 665–674.